Acoltremon Patent Expiration
Acoltremon was first introduced by Alcon Laboratories Inc
Acoltremon Patents
Given below is the list of patents protecting Acoltremon, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tryptyr | US11850221 | Ophthalmic pharmaceutical compositions and uses thereof | Dec 16, 2042 | Alcon Labs Inc |
| Tryptyr | US10028920 | Methods for treating occular irritation involving tearing by administering modulators of TRPM8 | Sep 08, 2031 | Alcon Labs Inc |
| Tryptyr | US9095609 | Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia | Sep 08, 2031 | Alcon Labs Inc |
| Tryptyr | US9433679 | Use of TRMP8 for treating opthalmic diseases or conditions involving tearing | Sep 08, 2031 | Alcon Labs Inc |
Acoltremon's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List